TATA INDIA PHARMA & HEALTHCARE FUND holds 44 instruments (99.72% equity), led by Sun Pharmaceutical Industries Limited (7.99%), Abbott India Limited (5.94%) and Healthcare Global Enterprises Limited (5.92%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of TATA INDIA PHARMA & HEALTHCARE FUND, managed by Tata Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 44 instruments with an equity allocation of 99.72%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
TATA INDIA PHARMA & HEALTHCARE FUND's top 10 holdings account for 50.53% of its portfolio, in line with the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 88.97% of net assets, spread across 3 sectors in total. Since its 31 August 2026 disclosure, the fund added 4 new positions and exited 3 positions, with Torrent Pharmaceuticals Limited seeing the largest move (+3.64pp to 3.76%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Torrent Pharmaceuticals Limited | 0.12% → 3.76% | ▲ +3.64 |
| PI Industries Limited | 0.95% → 2.59% | ▲ +1.64 |
| Abbott India Limited | 5.44% → 5.94% | ▲ +0.5 |
| Acutaas Chemicals Limited | 1.48% → 1.95% | ▲ +0.47 |
| Dr. Reddy's Laboratories Limited | 4.21% → 4.65% | ▲ +0.44 |
| Anthem Biosciences Limited | 2.14% → 2.57% | ▲ +0.43 |
| Procter & Gamble Health Limited | 2.51% → 2.75% | ▲ +0.24 |
| SYMBIOTEC PHARMALAB LTD | 0.64% → 0.87% | ▲ +0.23 |
| Sai Life Sciences Limited | 2.41% → 2.6% | ▲ +0.19 |
| FDC Limited | 2.1% → 2.24% | ▲ +0.14 |
| Stock | Weight | Change |
|---|---|---|
| Mankind Pharma Limited | 2.91% → 0.77% | ▼ -2.14 |
| GlaxoSmithKline Pharmaceuticals Limited | 2.72% → 0.76% | ▼ -1.96 |
| Fortis Healthcare Limited | 3.3% → 1.95% | ▼ -1.35 |
| MANIPAL HEALTH ENTERPRISES L | 1.24% → 0.59% | ▼ -0.65 |
| Sun Pharmaceutical Industries Limited | 8.43% → 7.99% | ▼ -0.44 |
| Pfizer Limited | 2.92% → 2.5% | ▼ -0.42 |
| Healthcare Global Enterprises Limited | 6.3% → 5.92% | ▼ -0.38 |
| MOLBIO DIAGNOSTICS LTD | 0.87% → 0.54% | ▼ -0.33 |
| Biocon Limited | 0.99% → 0.69% | ▼ -0.3 |
| Jubilant Pharmova Limited | 0.25% → 0% | ▼ -0.25 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Tata Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.